Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,599 | 357 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $865.16 | 61 | $0 (2024) |
| Lilly USA, LLC | $541.41 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $533.63 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $462.42 | 29 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $440.27 | 37 | $0 (2020) |
| PFIZER INC. | $352.10 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $307.94 | 19 | $0 (2020) |
| Abbott Laboratories | $301.91 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $298.12 | 18 | $0 (2024) |
| Amgen Inc. | $195.07 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $652.83 | 35 | Novo Nordisk Inc ($154.16) |
| 2023 | $663.35 | 33 | Daiichi Sankyo Inc. ($135.56) |
| 2022 | $883.68 | 47 | Lilly USA, LLC ($146.57) |
| 2021 | $56.67 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($56.67) |
| 2020 | $137.31 | 10 | Novo Nordisk Inc ($39.09) |
| 2019 | $900.78 | 65 | Novo Nordisk Inc ($180.23) |
| 2018 | $980.07 | 72 | Novo Nordisk Inc ($180.54) |
| 2017 | $1,331 | 93 | Janssen Pharmaceuticals, Inc ($192.94) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.70 | General |
| 11/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes Care | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Obesity | ||||||
| 08/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.09 | General |
| 06/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: DIABETES | ||||||
| 06/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Obesity | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Obesity | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes Care | ||||||
| 04/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 04/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,095 | 1,699 | $497,570 | $95,959 |
| 2022 | 24 | 1,223 | 1,823 | $514,565 | $113,502 |
| 2021 | 23 | 1,319 | 1,721 | $452,835 | $106,438 |
| 2020 | 25 | 1,283 | 1,896 | $428,295 | $101,597 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 483 | $205,275 | $38,189 | 18.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $13,800 | $8,107 | 58.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 56 | $29,400 | $6,914 | 23.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 33 | 33 | $39,600 | $5,545 | 14.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 55 | 55 | $37,125 | $4,566 | 12.3% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 39 | 39 | $35,100 | $4,507 | 12.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 77 | 77 | $15,400 | $4,100 | 26.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 29 | 29 | $27,550 | $3,462 | 12.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 40 | 40 | $16,000 | $3,393 | 21.2% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 93 | 193 | $12,545 | $2,143 | 17.1% |
| 93931 | Ultrasound of one arm arteries or artery grafts | Office | 2023 | 30 | 30 | $19,500 | $2,058 | 10.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 15 | 15 | $5,625 | $1,962 | 34.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 76 | 76 | $1,900 | $1,271 | 66.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,260 | $1,235 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 69 | 69 | $1,725 | $1,154 | 66.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $3,200 | $1,151 | 36.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 25 | 60 | $4,500 | $973.20 | 21.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 25 | 60 | $2,100 | $972.00 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $4,500 | $915.74 | 20.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 26 | 26 | $5,200 | $870.74 | 16.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 71 | 81 | $7,695 | $717.98 | 9.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 20 | $3,250 | $692.40 | 21.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $510.00 | $499.80 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 40 | $3,600 | $358.05 | 9.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 14 | $280.00 | $117.60 | 42.0% |
About Dr. Bo Wang, MD
Dr. Bo Wang, MD is a Internal Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386643260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bo Wang, MD has received a total of $5,605 in payments from pharmaceutical and medical device companies, with $652.83 received in 2024. These payments were reported across 358 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,599).
As a Medicare-enrolled provider, Wang has provided services to 4,920 Medicare beneficiaries, totaling 7,139 services with total Medicare billing of $417,496. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Frisco, TX
- Active Since 07/21/2005
- Last Updated 03/17/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386643260
Products in Payments
- JARDIANCE (Drug) $455.30
- JANUVIA (Drug) $273.75
- Victoza (Drug) $204.98
- Ozempic (Drug) $201.81
- XARELTO (Drug) $197.11
- Prolia (Biological) $170.72
- MOUNJARO (Drug) $167.76
- NURTEC ODT (Drug) $154.43
- FREESTYLE LIBRE 3 (Device) $152.64
- ANORO (Drug) $149.57
- FARXIGA (Drug) $147.64
- SHINGRIX (Biological) $136.87
- Enhertu (Drug) $135.56
- TRULICITY (Drug) $129.42
- Tresiba (Drug) $118.50
- Rybelsus (Drug) $112.12
- INVOKANA (Drug) $110.83
- Kerendia (Drug) $105.56
- Xhance (Drug) $105.24
- EMGALITY (Drug) $104.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Frisco
Jasbir Dhawan, Md, MD
Internal Medicine — Payments: $320,303
Jason Riehs, Md, MD
Internal Medicine — Payments: $201,897
Dr. Naveen Sikka, M.d, M.D
Internal Medicine — Payments: $96,322
Dr. Sibi Thomas, D.o, D.O
Internal Medicine — Payments: $75,591
Stephanie Berg, Md, MD
Internal Medicine — Payments: $42,134
Ramesh Amara, Md, MD
Internal Medicine — Payments: $13,128